Literature DB >> 10025439

Motion perception in schizophrenia.

Y Chen1, G P Palafox, K Nakayama, D L Levy, S Matthysse, P S Holzman.   

Abstract

BACKGROUND: Eye-tracking dysfunction has been found in many patients with schizophrenia and in about 40% of their first-degree biological relatives. We hypothesized that a deficit in motion processing is associated with eye-tracking dysfunction because both motion signals and the brain regions responsible for processing motion signals are implicated in the generation of smooth pursuit. We examined several aspects of visual perception, including motion perception, in patients with schizophrenia.
METHODS: To evaluate motion perception, contrast sensitivity for velocity discrimination was measured in patients with schizophrenia (n=15) and normal control subjects (n=18). Contrast sensitivities for orientation discrimination and contrast detection were measured as control tasks.
RESULTS: Patients with schizophrenia showed significantly lower contrast sensitivity (ie, higher thresholds) than normal controls for the discrimination of small velocity differences (eg, 11 vs 9 degrees/s). This reduction in contrast sensitivity was severe (up to 10-fold) in about 40% of the patients. No group differences were found on the other tasks.
CONCLUSION: The discrimination of small velocity differences is impaired in a subgroup of patients with schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10025439     DOI: 10.1001/archpsyc.56.2.149

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  62 in total

1.  Early-stage visual processing deficits in schizophrenia.

Authors:  Pamela D Butler; Daniel C Javitt
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

2.  Schizophrenia patients show augmented spatial frame illusion for visual and visuomotor tasks.

Authors:  Y Chen; R McBain; D Norton; D Ongur
Journal:  Neuroscience       Date:  2010-10-30       Impact factor: 3.590

Review 3.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Brain Res Bull       Date:  2010-04-24       Impact factor: 4.077

4.  A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia.

Authors:  Isaac Schechter; Pamela D Butler; Maria Jalbrzikowski; Roey Pasternak; Alice M Saperstein; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

Review 5.  [One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging].

Authors:  H Tost; A Meyer-Lindenberg; M Ruf; T Demirakça; O Grimm; F A Henn; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

6.  Magnocellular contributions to impaired motion processing in schizophrenia.

Authors:  Dongsoo Kim; Glenn Wylie; Roey Pasternak; Pamela D Butler; Daniel C Javitt
Journal:  Schizophr Res       Date:  2005-12-01       Impact factor: 4.939

7.  Prolonged temporal interaction for peripheral visual processing in schizophrenia: evidence from a three-flash illusion.

Authors:  Yue Chen; Daniel Norton; Charles Stromeyer
Journal:  Schizophr Res       Date:  2014-05-10       Impact factor: 4.939

8.  Smooth-pursuit eye movement and directional motion-contrast sensitivity in schizophrenia.

Authors:  Walter L Slaghuis; Alison C Bowling; Rebecca V French
Journal:  Exp Brain Res       Date:  2005-08-02       Impact factor: 1.972

9.  Patterns of visual sensory and sensorimotor abnormalities in autism vary in relation to history of early language delay.

Authors:  Yukari Takarae; Beatriz Luna; Nancy J Minshew; John A Sweeney
Journal:  J Int Neuropsychol Soc       Date:  2008-11       Impact factor: 2.892

10.  What's in a face? Effects of stimulus duration and inversion on face processing in schizophrenia.

Authors:  Pamela D Butler; Arielle Tambini; Galit Yovel; Maria Jalbrzikowski; Rachel Ziwich; Gail Silipo; Nancy Kanwisher; Daniel C Javitt
Journal:  Schizophr Res       Date:  2008-05-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.